human health impact News
-
SAB to Discuss COVID-19 Review Panel’s Draft Report
The Science Advisory Board (SAB) of the U.S. Environmental Protection Agency (EPA) announced that it will convene the Chartered SAB meeting on May 20, 2020, to review and discuss the draft report prepared by the SAB COVID-19 Review Panel. The draft report, SAB Technical Review of EPA’s Identification of Research Needs to Address the Environmental and Human Health Impacts of COVID-19, was ...
-
EPA awards contracts to U.S. companies to screen chemicals for human health impacts
The U.S. Environmental Protection Agency’s (EPA) ToxCast chemical screening program has awarded contracts to four United States-based companies to test up to 10,000 chemicals for potential toxicity to people and the environment. ToxCast is designed to determine how chemical exposures affect human health. When fully implemented, ToxCast will be able to screen thousands of chemicals in fast, ...
-
Federal cleanup promised at site in Michigan and accelerated assessment on human health impacts
Administrator Lisa P. Jackson has committed to a federal leadership role in expediting the ongoing cleanup of the Michigan Dow Dioxin site and an acceleration of the Environmental Protection Agency’s overall scientific review of dioxins. “EPA is stepping up our commitment to this site, in partnership with the state of Michigan, so that we can accelerate this cleanup and deal with the pressing ...
-
SAB to Review EPA Research on Large Scale Disinfection of COVID-19 Virus
On April 20, 2020, the U.S. Environmental Protection Agency (EPA) announced that EPA Administrator Wheeler has requested that the Science Advisory Board (SAB) provide feedback on research needs concerning SARS-CoV-2 (the virus that causes COVID-19). This research is intended to help EPA understand and mitigate the environmental and human health impacts from COVID-19, and identifies EPA research ...
-
EPA urges Citizens to clear out medicine cabinets for drug take-back events (HQ)
The U.S. Environmental Protection Agency (EPA) is lending its support and expertise for drug take-back events sponsored by the U.S. Drug Enforcement Agency (DEA). The events will take place at 1,700 sites around the country on Saturday, September 25 from 10 a.m. to 2 p.m. Citizens may bring unwanted solid prescription and over-the-counter medicines to any of these locations so they may be ...
-
Premier Healthcare Alliance Endorses Standardized Environmentally Preferable Products and Services Tool
The Premier healthcare alliance has endorsed Practice Greenhealth’s (PGH) Greening the Supply Chain Initiative and its industry standard tool for medical product procurement. The Greening the Supply Chain Initiative brings together leaders in all sectors of healthcare to initiate dialogue on ways to create products with reduced environmental and human ...
-
The economic impact of noise pollution on human health
A recent report has assessed the latest research on the adverse affects of noise on health, focusing on approaches to estimating the economic cost of noise. This information could help policy makers tasked with designing cost-effective noise reduction and management policies. Increased traffic noise and the wider spread of a 24 hour society have contributed to rising complaints about ...
-
Evox Therapeutics Expands Its Exosome Patent Portfolio
Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted a new European patent, EP3706796, to add to its growing patent portfolio. This patent covers exosomes loaded with nucleic acids or ribonuclear protein complexes. The granted claims add to Evox’s patent estate, providing further ...
-
Streptococcus pneumoniae Exposed in New Online Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate the public about issues that may impact their health. The latest educational video discusses Streptococcus pneumoniae infections and how they may impact human health. Streptococcus pneumoniae, or pneumococcus, is a type of Gram-positive bacteria. It can often be found in ...
-
Biocom Names Winners of Third Annual Life Science Catalyst Awards
Biocom, the association representing the California life science industry, today announced the winners of its third annual Life Science Catalyst Awards. The program celebrates up-and-coming entrepreneurs, academics, investors, corporate leaders and business advisers who are making a lasting and positive mark on Southern California’s life science industry prior to reaching their 40th ...
-
Enterome announces first patient dosed in a Phase 1/2 trial with second OncoMimicsTM vaccine, EO2463, in non-Hodgkin lymphoma
EO2463 is an innovative, off-the-shelf microbiome-peptide based cancer vaccine • EO2463 combines four microbiome-peptides of B lymphocytes-specific lineage markers designed to induce the full depletion of malignant B lymphocytes ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut ...
By Enterome
-
Agilent Technologies Sponsors Duquesne University Symposium on Exposomics, Toxicity Pathways in Human Health
Agilent Technologies Inc. (NYSE: A) today announced it is sponsoring a free scientific symposium on exposomics and the etiology of disease. A panel of scientists from Duquesne University, The Children's Institute of Pittsburgh and The Heinz Endowments will discuss analytical strategies for measuring how environmental exposure impacts human health and chronic disease. The half-day event, "Regional ...
-
EPUK calls for consistency and clarity in approach to planning policy
EPIK recently responded to the draft National Policy Statement on Waste Water. In our response, we called on Government departments to take a more integrated approach to planning policy, and called for more consistency in the process being set out in National Policy Statements. We also asked for greater emphasis on the potential for development impact on human health and well being, alongside ...
-
Norovirus Outbreaks Impact Both Human Health and Businesses
An article published this year in USA Today described a double outbreak of the norovirus on a single cruise ship providing vacation trips departing that departed from San Francisco to Alaska. Both outbreaks occurred on the 2,000 passenger luxury cruise ship in May. On the first voyage over 140 passengers and crew became ill with norovirus symptoms. The second cruise, which departed 10 days ...
-
EPA reaction to DecaBDE phaseout announcement
As a result of negotiations with the U.S. Environmental Protection Agency, several companies announced today they will undertake a three year phaseout of decabromodiphenyl ether (DecaBDE), a persistent and toxic chemical that has been used as a flame retardant in consumer and other products. Steve Owens, EPA assistant administrator for the Office of Prevention, Pesticides and Toxic Substances, ...
-
Individual non-methane VOCs have large impacts on human health
Emissions of non-methane volatile organic compounds (NMVOCs) can have damaging effects on human health. New research has now revealed that only three substances out of a large number of NMVOCs are responsible for almost all damaging effects on human health. Air pollution policies should be designed to target these substances specifically, rather than overall NMVOC emissions, the researchers ...
-
EPA holds seminar on air pollution and cardiovascular disease
The U.S. Environmental Protection Agency is sponsoring a seminar called “Breathe Cleaner, Live Longer: Understanding Air Pollution after 40 Years.” The event is co-sponsored by the American Heart Association and the U.S. House of Representatives Committee on Science and Technology. World-renowned scientific experts will discuss the impacts of air pollution on life expectancy and ...
-
Vaxxinity to Participate at the Jefferies Healthcare Conference
Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that Mei Mei Hu, President and Chief Executive Officer of Vaxxinity, will participate in a fireside chat at the Jefferies Healthcare Conference, being held in New York, NY on Thursday, June 9, 2022 at 11:30 a.m. ET. A live webcast of the fireside chat can be ...
By Vaxxinit
-
Vaxxinity to Participate at the Bank of America Securities 2022 Healthcare Conference
Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that Mei Mei Hu, President and Chief Executive Officer of Vaxxinity, will participate in a fireside chat at the Bank of America Securities 2022 Healthcare Conference, being held in Las Vegas, Nevada on Thursday, May 12, 2022 at 10:40 a.m. PT. A live webcast of ...
By Vaxxinit
-
NRDC Sues EPA to Block New Pesticide That Threatens Monarch Butterflies, Human Health
The Natural Resources Defense Council today filed suit to block the use of a powerful, newly approved weed killer that will wreak further destruction on monarch butterfly populations already devastated by agricultural chemicals and poses risks to human health. The suit was filed in the D.C. Circuit court immediately after the Environmental Protection Agency approved the use of “Enlist ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you